DR info

Clinical trials : 9 / Drugs : 5 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 51

Focal cortical dysplasia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
137	Focal cortical dysplasia	-
157	Sturge-Weber syndrome	1.000
158	Tuberous sclerosis	1.000
192	Cockayne syndrome	1.000
222	Primary nephrotic syndrome	1.000
256	Muscle glycogenosis	1.000
277	Lymphangiomatosis	1.000
278	Huge lymphatic malformation with cervicofacial lesion	1.000
279	Huge venous malformation with cervical, oral and pharyngeal diffuse lesion	1.000
280	Huge arteriovenous malformation with cervicofacial or limb lesion	1.000
281	Klippel-Trenaunay-Weber syndrome	1.000
283	Acquired pure red cell aplasia	1.000
285	Fanconi anemia	1.000
331	Idiopathic multicentric castleman disease	1.000
228	Bronchiolitis obliterans	1.000
36	Epidermolysis bullosa	1.000
13	Multiple sclerosis/Neuromyelitis optica	1.000
193	Prader-Willi syndrome	1.000
6	Parkinson disease	1.000
2	Amyotrophic lateral sclerosis	1.000
62	Paroxysmal nocturnal hemoglobinuria	1.000
63	Idiopathic thrombocytopenic purpura	1.000
15	Inclusion body myositis	1.000
17	Multiple system atrophy	1.000
19	Lysosomal storage disease	1.000
34	Neurofibromatosis	1.000
35	Pemphigus	1.000
46	Malignant rheumatoid arthritis	1.000
49	Systemic lupus erythematosus	1.000
51	Scleroderma	1.000
60	Aplastic anemia	1.000
61	Autoimmune hemolytic anemia	1.000
65	Primary immunodeficiency	1.000
66	IgA nephropathy	1.000
67	Polycystic kidney disease	1.000
84	Sarcoidosis	1.000
85	Idiopathic interstitial pneumonia	1.000
86	Pulmonary arterial hypertension	1.000
89	Lymphangioleiomyomatosis	1.000
96	Crohn disease	1.000
98	Eosinophilic gastrointestinal disease	1.000
127	Frontotemporal lobar degeneration	1.000